Caribou Biosciences Inc

NASDAQ:CRBU   3:59:50 PM EDT
26.49
+2.20 (+9.06%)
4:28:13 PM EDT: $26.40 -0.09 (-0.34%)
Earnings Announcements

Caribou Biosciences Provides Business Update

Published: 09/02/2021 20:34 GMT
Caribou Biosciences Inc (CRBU) - Caribou Biosciences Provides Business Update and Reports Second Quarter 2021 Financial Results.
Caribou Biosciences - Revenue Generated From Co's Licensing and Collaboration Agreements Was $1.5 Million for Q2 of 2021.
Caribou Biosciences Inc Qtrly Net Loss per Share, Basic and Diluted$1.39.
Revenue is expected to be $16.5 Million
Adjusted EPS is expected to be -$0.12

Next Quarter Revenue Guidance is expected to be $7.94 Million
Next Quarter EPS Guidance is expected to be -$0.25

More details on our Analysts Page.